Sakar Healthcare Q1 FY2027 Board Meeting Notice

Date: 20th July, 2026

Meeting of the Board of Directors scheduled to be held on 24th July, 2026
Primary agenda: To consider and approve the Unaudited Financial Results of the Company for the quarter ended on 30th June, 2026 (Q1 FY2027)
Secondary agenda: To consider other matters (nature not specified)

Disclosure made pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015
Trading window closure for designated persons continues as previously intimated to the Exchange via letter dated 26th June, 2026
Trading window shall remain closed until 48 hours after the declaration of Financial Results for the quarter ended 30th June, 2026
Trading window closure implemented in terms of Company's Code of Conduct for prevention of Insider Trading and SEBI (Prohibition of Insider Trading) Regulations, 2015